| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |